NS

Naddimulla Sadik Ikbalhussain

Active Director Director DIN 10363440
DIN 10363440 First appointment Oct 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Naddimulla Sadik Ikbalhussain

Data last updated:

Naddimulla Sadik Ikbalhussain is a Director at Britanica Health Private Limited (since 2023). The company operates in Paper.

DIN 10363440
Primary Designation Director
Industry Paper
First Appointment 19 Oct 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Britanica Health Private Limited U21009TS2023PTC178267
Director19 Oct 20232023Active

Board colleagues of Naddimulla Sadik Ikbalhussain

Directorship timeline

Open interactive timeline →
Britanica Health Private Limited
Premium access

Shareholding and investment profile for Naddimulla Sadik Ikbalhussain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Naddimulla Sadik Ikbalhussain

Naddimulla Sadik Ikbalhussain currently holds 1 directorship: Britanica Health Private Limited (Director, since 19 Oct 2023).

Naddimulla Sadik Ikbalhussain was first appointed on 19 Oct 2023 as Director at Britanica Health Private Limited.

The current boards of Naddimulla Sadik Ikbalhussain's companies include Ashrf Abubakr M Elhoush (Britanica Health Private Limited), Hussein Mohamed Ramadan (Britanica Health Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available